MicroRNAs and their delivery in diabetic fibrosis

Area of Science:

• Genomics
• Molecular Biology
• Endocrinology

Background:

• Diabetes mellitus is a global epidemic, affecting 463 million people in 2019 and projected to reach 700 million by 2045.
• Understanding diabetes pathology and complications is crucial for improving patient outcomes and reducing healthcare costs.
• The role of noncoding RNA, particularly microRNAs, in gene regulation is an evolving area of research.

Purpose of the Study:

• To investigate the significance of microRNA expression in diabetes mellitus and its complications.
• To explore the potential of microRNAs as therapeutic targets and biomarkers for diabetes.

Main Methods:

• Analysis of microRNA expression profiles in diabetes and its complications.
• Review of existing literature on microRNA function and regulation in the context of diabetes.

Main Results:

• Altered microRNA expression profiles have been consistently observed in patients with diabetes.
• MicroRNA dysregulation is implicated in the development and progression of diabetic complications.
• MicroRNAs regulate a significant portion of the human genome, highlighting their broad impact.

Conclusions:

• MicroRNAs represent a novel class of molecules with significant potential in diabetes research.
• Altered microRNA expression suggests their utility as biomarkers for diabetes diagnosis and prognosis.
• MicroRNAs hold promise as targets for the development of innovative therapeutic strategies for diabetes and its complications.